| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |